---
schema_version: "secwatch.filing_event.v1"
accession: "0001062993-26-001326"
form_type: "8-K"
ticker: "MDCX"
cik: "0001997296"
company_name: "Medicus Pharma Ltd."
filed_at: "2026-03-06T23:59:59+00:00"
generated_at: "2026-05-15T19:03:03.850594+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Medicus Pharma sells 4.47M shares for $3.85M under Yorkville SEPA through Mar 6, 2026

## Summary
- Total of 4,471,038 common shares sold under SEPA from Dec 2025 to Mar 2026 for aggregate $3,846,910.
- Largest single draw: 1,425,000 shares on Mar 6, 2026 for approx $640,110.
- Proceeds used partly to prepay outstanding debenture with Yorkville (previously disclosed in Sep 2025 8-K).
- Yorkville may resell shares under an effective registration statement; additional draws possible subject to SEPA conditions.
- Sales rely on Section 4(a)(2) exemption; Yorkville represented itself as an accredited investor.

## SEC filing metadata
- accession: 0001062993-26-001326
- form_type: 8-K
- ticker: MDCX
- cik: 0001997296
- company_name: Medicus Pharma Ltd.
- filed_at: 2026-03-06T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1997296/000106299326001326/0001062993-26-001326-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1997296/000106299326001326/form8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001062993-26-001326
- JSON: https://secwatch.observer/filing/0001062993-26-001326.json
- Plain text: https://secwatch.observer/filing/0001062993-26-001326.txt

## Key facts
- Equity Issuances
  Medicus Pharma Ltd. issued 4,471,038 of common stock to YA II PN, Ltd. for $3,846,910.
  - Security: common stock
  - Shares: 4,471,038
  - Purchaser: YA II PN, Ltd.
  - Consideration: $3,846,910
  source text: the Company completed sales of its common shares (the "Common Shares") to Yorkville (collectively, the "SEPA Advances") as disclosed in the table below: Date of Sale Number of Common Shares Approximate Aggregate Consideration December 19, 2025 66,667 $113,647 December 19, 2025 5,432 $9,221 December 29, 2025 41,250 $66,149 December 29, 2025 20,909 $32,451 January 9, 2026 100,000 $150,640 January 15, 2026 33,333 $48,006 January 15, 2026 11,347 $15,960 January 29, 2026 7,100 $8,609 February 10, 2026 175,000 $186,603 February 18, 2026 250,000 $237,200 February 23, 2026 275,000 $302,088 March 5, 2026 700,000 $988,890 March 5, 2026 1,360,000 $1,047,336 March 6, 2026 1,425,000 $640,110 Total 4,471,038 $3,846,910
  evidence_url: https://www.sec.gov/Archives/edgar/data/1997296/000106299326001326/0001062993-26-001326-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.